The eIF2α serine 51 phosphorylation-ATF4 arm promotes HIPPO signaling and cell death under oxidative stress

Abstract

The HIPPO pathway is an evolutionary conserved regulator of organ size that controls both cell proliferation and death. This pathway has an important role in mediating cell death in response to oxidative stress through the inactivation of Yes-associated protein (YAP) and inhibition of anti-oxidant gene expression. Cells exposed to oxidative stress induce the phosphorylation of the alpha (α) subunit of the translation initiation factor eIF2 at serine 51 (eIF2αP), a modification that leads to the general inhibition of mRNA translation initiation. Under these conditions, increased eIF2αP facilitates the mRNA translation of activating transcription factor 4 (ATF4), which mediates either cell survival and adaptation or cell death under conditions of severe stress. Herein, we demonstrate a functional connection between the HIPPO and eIF2αP-ATF4 pathways under oxidative stress. We demonstrate that ATF4 promotes the stabilization of the large tumor suppressor 1 (LATS1), which inactivates YAP by phosphorylation. ATF4 inhibits the expression of NEDD4.2 and WWP1 mRNAs under pro-oxidant conditions, which encode ubiquitin ligases mediating the proteasomal degradation of LATS1. Increased LATS1 stability is required for the induction of cell death under oxidative stress. Our data reveal a previously unidentified ATF4-dependent pathway in the induction of cell death under oxidative stress via the activation of LATS1 and HIPPO pathway.

ACADL plays a tumor-suppressor role by targeting Hippo/YAP signaling in hepatocellular carcinoma

“…It was reported that downregulation of ACADL reduces ROS and increases cellular fatty acids, and ACADL itself directly produces ROS 9,22 . In addition, it has been reported that ROS or fatty acids overload inhibited YAP activation through regulating LATS1/2 23,24 . Thus, it is possible that ACADL may regulate the YAP activity through modulating ROS or fatty acid levels.…”

The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas

“…First, the redox master regulator ATF4 is abundantly expressed in glioblastoma specimens and cell lines [ 28 ]. Second, inhibition of ATF4 can induce cancer cell death in some cancer cells such as osteosarcoma, lymphomas and epithel cell derived tumors [ 17 , 20 , 29 , 30 ].…”

Senescence of alveolar stem cells drives progressive pulmonary fibrosis

“…Upregulated pathways in Sin3a-LOF AT2 cells included oxidative phosphorylation, mitochondrial dysfunction, sirtuin signaling, EIF2 signaling, and mTOR signaling. Interestingly, these pathways are all linked to cellular senescence (38)(39)(40)(41)(42)(43)(44)(45)(46)(47)(48)(49)(50)(51)(52)(53).…”